Vita Life Sciences And 2 Other Australian Biotech Stocks To Own
Inflation has been running hot in the United States, with the October consumer price index and producer prices both above central bank targets, and major central banks signalling they are prepared to keep interest rates higher for longer. In that kind of backdrop, businesses where value comes from research, intellectual property and science, rather than heavy assets, may be relatively better positioned. This article highlights three Australian biotech stocks with balance sheets that may...
Inflation has been running hot in the United States, with the October consumer price index and producer prices both above central bank targets, and major central banks signalling they are prepared to keep interest rates higher for longer. In that kind of backdrop, businesses where value comes from research, intellectual property and science, rather than heavy assets, may be relatively better positioned. This article highlights three Australian biotech stocks with balance sheets that may...
What's Your Reaction?
